ClassID:

92363 āŽ˜

C07C205/35 - CPC Classification

Classification description:

Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton

Sub-classes:
Recent Application in this class:
#1
20200299755
2020-09-24

Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes

#2
20180258471
2018-09-13

Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes

#3
20150250793
2015-09-10

BAX agonist, compositions, and methods related thereto

#4
20140178374
2014-06-26

BAX agonist, compositions, and methods related thereto

#5
20130023663
2013-01-24

Substituted stilbenes and their reactions

#6
20110166117
2011-07-07

Novel Compounds

#7
20090312315
2009-12-17

PAI-1 inhibitor

#8
20090149445
2009-06-11

TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS

#9
20080177114
2008-07-24

Method for decarboxylating C—C cross-linking of carboxylic acids with carbon electrophiles

#10
20080004301
2008-01-03

Benzene compound having 2 or more substituents

#11
20070203217
2007-08-30

SUBSTITUTED STILBENES AND THEIR REACTIONS

#12
20070167632
2007-07-19

Method for synthesizing compound and catalyst for synthesis reaction

#13
20070060656
2007-03-15

Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof

#14
20060264435
2006-11-23

Compounds

#15
20060178356
2006-08-10

Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

#16
20060063759
2006-03-23

Tricyclic steroid hormone nuclear receptor modulators

#17
20050148801
2005-07-07

Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof

#18
20050142155
2005-06-30

Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

#19
20050113416
2005-05-26

Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

#20
20050065213
2005-03-24

Combretastatin a-4 derivatives having antineoplastic activity